Literature DB >> 25613992

HIV-1 adaptation to HLA: a window into virus-host immune interactions.

Jonathan M Carlson1, Anh Q Le2, Aniqa Shahid2, Zabrina L Brumme3.   

Abstract

HIV-1 develops specific mutations within its genome that allow it to escape detection by human leukocyte antigen (HLA) class I-restricted immune responses, notably those of CD8(+) cytotoxic T lymphocytes (CTL). HLA thus represents a major force driving the evolution and diversification of HIV-1 within individuals and at the population level. Importantly, the study of HIV-1 adaptation to HLA also represents an opportunity to identify what qualities constitute an effective immune response, how the virus in turn adapts to these pressures, and how we may harness this information to design HIV-1 vaccines that stimulate effective cellular immunity.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CD8(+) T-lymphocyte (CTL); adaptation; evolution; human immunodeficiency virus 1 (HIV-1); human leukocyte antigen (HLA) class I; immune escape

Mesh:

Substances:

Year:  2015        PMID: 25613992     DOI: 10.1016/j.tim.2014.12.008

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  47 in total

1.  Prevalence of Rilpivirine and Etravirine Resistance Mutations in HIV-1 Subtype C-Infected Patients Failing Nevirapine or Efavirenz-Based Combination Antiretroviral Therapy in Botswana.

Authors:  Thabo Diphoko; Simani Gaseitsiwe; Ishmael Kasvosve; Sikhulile Moyo; Harriet Okatch; Rosemary Musonda; Mark Wainberg; Joseph Makhema; Richard Marlink; Vladimir Novitsky; Max Essex
Journal:  AIDS Res Hum Retroviruses       Date:  2018-06-12       Impact factor: 2.205

2.  Analysis of the CD8+ T cell anti-HIV activity in heterologous cell co-cultures reveals the benefit of multiple HLA class I matches.

Authors:  M Scott Killian; Fernando Teque; Ramu Sudhagoni
Journal:  Immunogenetics       Date:  2017-07-22       Impact factor: 2.846

3.  Genotypic and Mechanistic Characterization of Subtype-Specific HIV Adaptation to Host Cellular Immunity.

Authors:  Natalie N Kinloch; Guinevere Q Lee; Jonathan M Carlson; Steven W Jin; Chanson J Brumme; Helen Byakwaga; Conrad Muzoora; Mwebesa B Bwana; Kyle D Cobarrubias; Peter W Hunt; Jeff N Martin; Mary Carrington; David R Bangsberg; P Richard Harrigan; Mark A Brockman; Zabrina L Brumme
Journal:  J Virol       Date:  2018-12-10       Impact factor: 5.103

4.  Immune Control of HIV.

Authors:  Muthukumar Balasubramaniam; Jui Pandhare; Chandravanu Dash
Journal:  J Life Sci (Westlake Village)       Date:  2019-06

Review 5.  Clinical and evolutionary consequences of HIV adaptation to HLA: implications for vaccine and cure.

Authors:  Santiago Avila-Rios; Jonathan M Carlson; Mina John; Simon Mallal; Zabrina L Brumme
Journal:  Curr Opin HIV AIDS       Date:  2019-05       Impact factor: 4.283

Review 6.  Antigenic variability: Obstacles on the road to vaccines against traditionally difficult targets.

Authors:  R Servín-Blanco; R Zamora-Alvarado; G Gevorkian; K Manoutcharian
Journal:  Hum Vaccin Immunother       Date:  2016-06-13       Impact factor: 3.452

7.  High polymorphism rates in well-known T cell epitopes restricted by protective HLA alleles during HIV infection are associated with rapid disease progression in early-infected MSM in China.

Authors:  Chuan He; Xiaoxu Han; Hui Zhang; Fanming Jiang; Minghui An; Bin Zhao; Haibo Ding; Zining Zhang; Tao Dong; Hong Shang
Journal:  Med Microbiol Immunol       Date:  2019-03-08       Impact factor: 3.402

8.  HLA Class I-Mediated HIV-1 Control in Vietnamese Infected with HIV-1 Subtype A/E.

Authors:  Takayuki Chikata; Giang Van Tran; Hayato Murakoshi; Tomohiro Akahoshi; Ying Qi; Vivek Naranbhai; Nozomi Kuse; Yoshiko Tamura; Madoka Koyanagi; Sachiko Sakai; Dung Hoai Nguyen; Dung Thi Nguyen; Ha Thu Nguyen; Trung Vu Nguyen; Shinichi Oka; Maureen P Martin; Mary Carrington; Keiko Sakai; Kinh Van Nguyen; Masafumi Takiguchi
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

Review 9.  The MHC in the era of next-generation sequencing: Implications for bridging structure with function.

Authors:  Effie W Petersdorf; Colm O'hUigin
Journal:  Hum Immunol       Date:  2018-10-12       Impact factor: 2.850

Review 10.  T-cell therapies for HIV: Preclinical successes and current clinical strategies.

Authors:  Shabnum Patel; R Brad Jones; Douglas F Nixon; Catherine M Bollard
Journal:  Cytotherapy       Date:  2016-06-02       Impact factor: 5.414

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.